1. Home
  2. ONVO vs LGHL Comparison

ONVO vs LGHL Comparison

Compare ONVO & LGHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONVO
  • LGHL
  • Stock Information
  • Founded
  • ONVO 2007
  • LGHL 2015
  • Country
  • ONVO United States
  • LGHL Singapore
  • Employees
  • ONVO N/A
  • LGHL N/A
  • Industry
  • ONVO Biotechnology: Biological Products (No Diagnostic Substances)
  • LGHL Investment Bankers/Brokers/Service
  • Sector
  • ONVO Health Care
  • LGHL Finance
  • Exchange
  • ONVO Nasdaq
  • LGHL Nasdaq
  • Market Cap
  • ONVO 5.3M
  • LGHL 4.3M
  • IPO Year
  • ONVO N/A
  • LGHL N/A
  • Fundamental
  • Price
  • ONVO $0.37
  • LGHL $0.15
  • Analyst Decision
  • ONVO
  • LGHL
  • Analyst Count
  • ONVO 0
  • LGHL 0
  • Target Price
  • ONVO N/A
  • LGHL N/A
  • AVG Volume (30 Days)
  • ONVO 103.2K
  • LGHL 1.9M
  • Earning Date
  • ONVO 02-19-2025
  • LGHL 03-04-2025
  • Dividend Yield
  • ONVO N/A
  • LGHL N/A
  • EPS Growth
  • ONVO N/A
  • LGHL N/A
  • EPS
  • ONVO N/A
  • LGHL N/A
  • Revenue
  • ONVO $122,000.00
  • LGHL $13,659,110.00
  • Revenue This Year
  • ONVO $59.08
  • LGHL N/A
  • Revenue Next Year
  • ONVO $18.24
  • LGHL N/A
  • P/E Ratio
  • ONVO N/A
  • LGHL N/A
  • Revenue Growth
  • ONVO N/A
  • LGHL 11.35
  • 52 Week Low
  • ONVO $0.32
  • LGHL $0.13
  • 52 Week High
  • ONVO $1.74
  • LGHL $1.14
  • Technical
  • Relative Strength Index (RSI)
  • ONVO 49.60
  • LGHL 50.11
  • Support Level
  • ONVO $0.33
  • LGHL $0.14
  • Resistance Level
  • ONVO $0.40
  • LGHL $0.15
  • Average True Range (ATR)
  • ONVO 0.03
  • LGHL 0.01
  • MACD
  • ONVO 0.00
  • LGHL 0.00
  • Stochastic Oscillator
  • ONVO 61.25
  • LGHL 46.19

About ONVO Organovo Holdings Inc.

Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.

About LGHL Lion Group Holding Ltd.

Lion Group Holding Ltd is an investor-focused trading platform that offers various products and services. The company's current business lines include total return swap (TRS) trading business, contracts for difference (CFD) trading services, Hong Kong-based Over-The-Counter (OTC) stock options trading business, and futures and securities brokerage services. It provides these services through its Lion Brokers Pro and a variety of other applications. The company generates a majority of its revenue from its CFD trading services business. Geographically, the firm's key revenue-generating market is Hong Kong.

Share on Social Networks: